ArticleESMO real world data and digital oncology2025

Effectiveness, toxicity and treatment adjustments of lenvatinib plus pembrolizumab in advanced renal cell carcinoma: a multicenter real-world analysis.

R Stelmach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.